Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Change in Account Payables (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Change in Account Payables for 16 consecutive years, with -$16291.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables rose 66.32% to -$16291.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$26735.0, a 71.33% increase, with the full-year FY2024 number at -$43850.0, up 98.51% from a year prior.
  • Change in Account Payables was -$16291.0 for Q3 2025 at Creative Medical Technology Holdings, down from -$8743.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.9 million in Q4 2022 to a low of -$2.9 million in Q1 2023.
  • A 5-year average of -$5465.3 and a median of -$1337.0 in 2025 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 856.51% in 2022; the steepest drop was 8453.21% in 2022.
  • Creative Medical Technology Holdings' Change in Account Payables stood at $307337.0 in 2021, then surged by 856.51% to $2.9 million in 2022, then plummeted by 101.69% to -$49765.0 in 2023, then surged by 99.27% to -$364.0 in 2024, then crashed by 4375.55% to -$16291.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Change in Account Payables are -$16291.0 (Q3 2025), -$8743.0 (Q2 2025), and -$1337.0 (Q1 2025).